Systemic Drainage
NDC 43742-2114, Alfalfa, Avena Sativa, Berberis Vulgaris, Chelidonium Majus, Citrus Limonum, Galium Aparine, Glycyrrhiza Glabra, Hepar Suis, Intestine (Suis), Kidney (Suis), Lacticum Acidum, Lung (Suis), Lymph Node (Suis), Magnesium Gluconate Dihydricum, Nux Vomica, Potassium Gluconate, Sarcolacticum Acidum, Schisandra Chinensis, Solidago Virgaurea, Tabacum, Taraxacum Officinale, Tylophora Asthmatica, Uva-Ursi, Zincum Gluconicum., liquid, from Deseret Biologicals, Inc..
- Product NDC
- 43742-2114
- Status
- Listed
- Labeler
- Deseret Biologicals, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43742-2114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEDICAGO SATIVA WHOLE1 [hp_X]/mL
- AVENA SATIVA FLOWERING TOP1 [hp_X]/mL
- BERBERIS VULGARIS ROOT BARK6 [hp_X]/mL
- CHELIDONIUM MAJUS WHOLE6 [hp_X]/mL
- LEMON JUICE1 [hp_X]/mL
- GALIUM APARINE WHOLE3 [hp_X]/mL
- GLYCYRRHIZA GLABRA1 [hp_X]/mL
- PORK LIVER6 [hp_X]/mL
- PORK INTESTINE6 [hp_X]/mL
- PORK KIDNEY6 [hp_X]/mL
- LACTIC ACID, DL-12 [hp_X]/mL
- SUS SCROFA LUNG6 [hp_X]/mL
- SUS SCROFA LYMPH6 [hp_X]/mL
- MAGNESIUM GLUCONATE6 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED8 [hp_X]/mL
- POTASSIUM GLUCONATE6 [hp_X]/mL
- LACTIC ACID, L-8 [hp_X]/mL
- SCHISANDRA CHINENSIS FRUIT3 [hp_X]/mL
- SOLIDAGO VIRGAUREA FLOWERING TOP3 [hp_X]/mL
- TOBACCO LEAF4 [hp_X]/mL
- TARAXACUM OFFICINALE2 [hp_X]/mL
- VINCETOXICUM INDICUM LEAF33 [hp_C]/mL
- VINCETOXICUM INDICUM ROOT33 [hp_C]/mL
- ARCTOSTAPHYLOS UVA-URSI LEAF1 [hp_X]/mL
- ZINC GLUCONATE6 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Plant Proteins [CS]; Plant Proteins [CS]; Plant Proteins [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Seed Storage Proteins [CS]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43742-2114-1 | 43742211401 | 60 mL in 1 BOTTLE, DROPPER (43742-2114-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43742-2114 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43742-2114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43742-2114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.